#59 - Cell-ebrate good times, come on!

#58 - Choc, stock and two smoking trials

#57 - AI sharpens up, Merck makes cuts & FDA yields

#56 - Spud-tacular developments & starchy standoffs

#55 - Of mice, cats, and medicine

#54 - Moss-powered medicines & the next Moderna

#53 - All aboard the funding flight!

#52 - Hydrogen snacks, metabolic acts & policy quacks

#51 - Genetic wins and ChatGPT biology

#50 - Zombie brains, phage gains & Recursion pains

#49 - Moo-ve over, milk’s got a biotech makeover

#48 - CRISPR twins, criminal grins & clinical crises